STEREOSELECTIVE DISPOSITION AND GLUCURONIDATION OF PROPRANOLOL IN HUMANS

被引：148

作者：

SILBER, B

HOLFORD, NHG

RIEGELMAN, S

机构：

[1] UNIV CALIF SAN FRANCISCO, SCH PHARM, DEPT PHARMACEUT CHEM, SAN FRANCISCO, CA 94143 USA

[2] UNIV CALIF SAN FRANCISCO, SCH PHARM, DEPT PHARM, SAN FRANCISCO, CA 94143 USA

[3] UNIV CALIF SAN FRANCISCO, SCH MED, DEPT MED, DIV CLIN PHARMACOL, SAN FRANCISCO, CA 94143 USA

来源：

JOURNAL OF PHARMACEUTICAL SCIENCES | 1982年 / 71卷 / 06期

关键词：

D O I：

10.1002/jps.2600710623

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：699 / 704

页数：6

共 43 条

[31] CLEARANCE CONCEPTS IN PHARMACOKINETICS [J].

ROWLAND, M ;

BENET, LZ ;

GRAHAM, GG .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1973, 1 (02) :123-136

[32] ESTIMATING DIMENSION OF A MODEL [J].

SCHWARZ, G .

ANNALS OF STATISTICS, 1978, 6 (02) :461-464

[33] INDIVIDUALIZATION OF PROPRANOLOL THERAPY [J].

SHAND, DG .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :1063-1069

[34]

SILBER B, 1980, J PHARMACOL EXP THER, V215, P643

[35]

SILBER B, 1980, RES COMMUN CHEM PATH, V27, P419

[36]

SILBER B, 1980, 29TH APHA AC PHARM S, V10, P76

[37] MASSIVE PROPRANOLOL METABOLITE RETENTION DURING MAINTENANCE HEMODIALYSIS [J].

STONE, WJ ;

WALLE, T .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) :449-455

[38]

VERVLOET E, 1978, CLIN PHARMACOL THER, V23, P133

[39]

VESTAL RE, 1979, CLIN PHARMACOL THER, V25, P19

[40]

VESTAL RE, 1979, CLIN PHARMACOL THER, V26, P8

← 1 2 3 4 5 →